Working with biologic drugs represents a huge analytical effort to deeply understand the whole molecule characteristics. Different methods and technologies are needed to get the analytical fingerprint. We can afford complex characterization projects of innovative biologics or biosimilars comparison. Our experience covers a range of biologics such as:
- Hormones and toxins
- Biosimilars (proteins and monoclonal antibodies)
- Innovative proteins or innovative monoclonal antibodies
- Antibody drug conjugates
- Therapeutic peptides: innovative, generic and hybrid formulations
- Polysaccharides: heparin and others
- Non-living vaccines